CEACAM5 and breast cancer: It has already been shown that CK19 and CEA molecular markers have good specificity [18], while CA15-3 and CEA serum markers have clinical significance and are the most widely used [22, 23]; furthermore, ER/PR and HER-2 receptors are clinically important tissue markers in BC [24].